Symbol="MTCR"
AssetType="Common Stock"
Name="MetacrineÂ Inc"
Description="Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with liver and gastrointestinal diseases. The company is headquartered in San Diego, California."
CIK="1634379"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3985 SORRENTO VALLEY BLVD., SUITE C, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2022-09-30"
MarketCapitalization="25484400"
EBITDA="-35998000"
PERatio="None"
PEGRatio="None"
BookValue="0.871"
DividendPerShare="0"
DividendYield="0"
EPS="-1.03"
RevenuePerShareTTM="0.241"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.369"
ReturnOnEquityTTM="-0.907"
RevenueTTM="2175000"
GrossProfitTTM="-45474000"
DilutedEPSTTM="-1.03"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="0.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.404"
EVToRevenue="-"
EVToEBITDA="0.67"
Beta="-0.742"
num_52WeekHigh="0.585"
num_52WeekLow="0.0014"
num_50DayMovingAverage="0.563"
num_200DayMovingAverage="0.495"
SharesOutstanding="43832800"
DividendDate="2023-06-20"
ExDividendDate="2023-06-21"
symbol="MTCR"
open="0.59"
high="0.59"
low="0.58"
price="0.58"
volume="83889.00"
latest_trading_day="2023-06-20"
previous_close="0.59"
change="-0.01"
change_percent="-1.2903%"
aroon_positive_momentum_days="95"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="95"
Volume_recent_avg="231585"
Change_recent_avg="0.01"
Delta_recent_avg="0.02"
Variance_recent_avg="0.01"
Change_ratio_recent_avg="0.81"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_10"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="95"
Aroon_momentum_negative="5"
image_negative_thumbnail_id_1="98"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0078.jpeg"
image_negative_thumbnail_id_2="493"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0112.jpeg"
image_neutral_thumbnail_id_1="546"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="991"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0153.jpeg"
image_positive_thumbnail_id_2="606"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0102.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
